Key facts
- This page summarizes John F. Crowley's Form 4 filing for Intellia Therapeutics, Inc. (NTLA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2023, 16:26.
John F. Crowley - 14 Jun 2023 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)
- Reporting relationship
- Director
- Issuer ticker
- NTLA
- Reported as of
- 14 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2023, 16:26:58 UTC
- Prior SEC filing
- 12 Jun 2023
- Next SEC filing
- 20 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/James Basta, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John F. Crowley filed Form 4 for Intellia Therapeutics, Inc. (NTLA) on 16 Jun 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NTLA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,425
- Change %
- +61%
- Price
- $0.000000
- Shares after
- 11,716
- Date
- 14 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NTLA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +6,473
- Change %
- Price
- $0.000000
- Shares after
- 6,473
- Date
- 14 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,473
- Exercise price
- $45.20
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
Footnote F2
This option was granted on June 14, 2023 with respect to 6,473 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.